XASE
AXIL
Market cap732mUSD
Jul 09, Last price
6.26USD
1D
1.95%
1Q
-10.70%
IPO
-71.55%
Name
Reviv3 Procare Co
Chart & Performance
P/E
857.21
P/S
27.91
EPS
0.01
Div Yield, %
—
Shrs. gr., 5y
31.82%
Rev. gr., 5y
91.76%
Revenues
26m
-4.51%
Net income
855k
-57.32%
CFO
2m
+71,945.61%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
AXIL Brands, Inc. engages in the manufacture, marketing, distribution, and sale of hearing and audio enhancement and protection products in the United States, Canada, Europe, Australia, New Zealand, Africa, and Asia. The company operates through Hearing Enhancement and Protection, and Hair and Skin Care segments. It provides ear plugs, earmuffs, ear buds, and outdoor speakers under the AXIL brand. The company also provides shampoo, conditioner, scalp treatments, styling aids, and skin health solutions under the Reviv3 Procare brand, as well as cleansing, conditioning, repair, protection, and volume enhancement products. It sells GS Extreme, a Bluetooth-enabled earbuds for sound enhancement and hearing protection; XCOR True Wireless, a Digital earbud with touch control; TRACKR Blu, a Bluetooth audio earmuffs with advanced sound enhancement and protection; and X-PRO, a passive ear protections. The company sells its products through direct-to-consumer e-commerce channels, various third-party online platforms, distributors, and salon partnerships. It serves the sporting goods, recreational, military, federal agent, law enforcement, tactical, and industrial sectors. The company was formerly known as Reviv3 Procare Company and changed its name to AXIL Brands, Inc. in February 2024. AXIL Brands, Inc. was incorporated in 2015 and is headquartered in Beverly Hills, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑05 | 2024‑05 | 2023‑05 | 2022‑05 | 2021‑05 | 2020‑05 | 2019‑05 | 2018‑05 | 2017‑05 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||